1-(1H-indol-1-yl)-3-(4-methylpiperazin-1 -yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (NE) and the serotonine (5-HT) activity and the monoamine reuptake for the treatment of vasomotor symptoms (VMS)

Details for Australian Patent Application No. 2005230900 (hide)

Owner Wyeth

Inventors Sabatucci, Joseph Peter; Mahaney, Paige Erin; Trybulski, Eugene John; Terefenko, Eugene Anthony; Vu, An Thien; Heffernan, Gavin David; Marella, Michael Anthony; Kim, Callain Younghee; Coghlan, Richard Dale; McComas, Casey Cameron; Zhang, Puwen; Cohn, Stephen Todd; Ye, Fei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005230900

PCT Pub. Number WO2005/097744

Priority 60/557,651 30.03.04 US; 60/569,863 11.05.04 US; 11/091,885 28.03.05 US

Filing date 29 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4045 (2006.01)

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 241/42 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 265/36 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097744 Priority application(s): WO2005/097744

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230901-Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)

2005230899-Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS)